abstract |
The invention provides biodegradable implants size for implantation in an ocular region and methods for treating medical conditions of the eye. The implants are formed from a mixture of hydrophilic end and hydrophobic end PLGA, and deliver active agents into an ocular region without a high burst release. Preferably the implant is made by a double extrusion process. Preferably at least 75% of the particles of the avtive agent have a diameter of less than 10 or 20 microns. |